Hemoglobin A 1c (HbA 1c ) reflects a time averaged blood glucose during the previous 2 -3 months, and is used as the gold standard for long-term follow-up of glycemic control. The same HbA 1c method was used both in the DCCT study published in 1993 [ 1 ] and the UKPDS study published in 1998 [ 2 ] . Following the development of a true reference method by IFCC [ 3 ] , it was stated in an international consensus that this reference method should be used by all manufacturers for the calibration methods used in the clinical laboratory [ 4 ] . A second consensus meeting was held in 2009, where the main issue was how the results should be presented to clinicians and patients, and how they should be reported in scientific journals [ 5 ] . In short, three conclusions were reached at this meeting: The original consensus where results are reported in both SI units (mmol/mol) and in derived NGSP/DCCT percent units remains the ideal to achieve global standardization. Some countries which reported both units have now moved on to single reporting of SI units. It is particularly important to dual report for an agreed period of time if countries intend to move from percent to SI units. Some countries have decided to continue to report only NGSP/ DCCT percent units as this better reflects clinical practice in that country. It is important that the whole county adopts a single approach to the reporting units so as not to cause confusion, and put patients at risk. Journals are recommended to use either HbA 1c or HbA1C as abbreviations.
Editors of journals and other printed material are strongly recommended to ensure that submitted manuscripts report HbA 1c in both SI (IFCC) and NGSP/DCCT units.
The 2010 statement was simultaneously published in eight journals: Annals of Clinical Biochemistry, Clinical
